| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c2c694cf40ce82c75b4bfa5b2cfe76ef
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3a2824b415c02c74078dc541f02942f3 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-564 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-564 |
| filingDate |
2008-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba514c1f6ed4bca5d176f328cd7636d1 |
| publicationDate |
2009-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2009062497-A2 |
| titleOfInvention |
Method for end-titre determination and the evaluation thereof by means of an indirect immunofluorescence assay |
| abstract |
The invention relates to a method for end-titre determination in the determination of antibodies against nuclear and cytoplasmic antigens in human sera by means of an indirect immunofluorescence assay. The invention further relates to a kit for in vitro diagnosis for determining antibodies against nuclear and cytoplasmic antigens in human sera by means of an indirect immunofluorescence assay and a computer program for evaluation and for determination of the end titre within the framework of said method. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102667483-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2011217190-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3757649-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011101487-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102667483-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2362222-A1 |
| priorityDate |
2007-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |